A 21-Day of Adjunctive Corticosteroid Use May Not Be Necessary for HIV-1-Infected Pneumocystis Pneumonia with Moderate and Severe Disease

BACKGROUND: The current guidelines recommend 21-day adjunctive corticosteroid therapy for HIV-1-infected pneumocystis pneumonia patients (HIV-PCP) with moderate-to-severe disease. Whether shorter adjunctive corticosteroid therapy is feasible in such patients is unknown. METHODS: We conducted a retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibata, Satoshi, Nishijima, Takeshi, Aoki, Takahiro, Tanabe, Yoshinari, Teruya, Katsuji, Kikuchi, Yoshimi, Kikuchi, Toshiaki, Oka, Shinichi, Gatanaga, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578946/
https://www.ncbi.nlm.nih.gov/pubmed/26393804
http://dx.doi.org/10.1371/journal.pone.0138926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578946/
https://www.ncbi.nlm.nih.gov/pubmed/26393804
http://dx.doi.org/10.1371/journal.pone.0138926

Ejemplares similares